CVnCoV Withdrawn Phase 3 Trials for Infections, Coronavirus / Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04838847A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19